干细胞之家 - 中国干细胞行业门户第一站

标题: A vibrator prevents streaming during close-arterial infusion into the kidney [打印本页]

作者: 轻羽    时间: 2009-4-22 08:15     标题: A vibrator prevents streaming during close-arterial infusion into the kidney

作者:Shereen M. Hamza and Susan Kaufman作者单位:Department of Physiology, University of Alberta, Edmonton, Alberta, Canada, T6G 2S2
% E7 x* Z! {# p% E                  
0 h/ K# D, w/ r8 _5 e                  
: J  R1 G8 f+ l+ n; O4 _          " M5 ?- {4 J: d' j) {: W6 j8 o7 k
                         ( ^: K4 q3 D! J7 a) V7 v
            8 @5 @0 |( A$ {/ w/ Q2 Q% y. ]
            : Q7 ^& t% Q& \2 v  K5 e! `
            
6 W! p, k1 z8 }) t) j; J1 `1 Q            # m" j2 u$ L* ?. @2 D, F, J
                     
1 e6 ^- M( z( B* R        7 ^. A5 N  Z6 G, g
        0 u3 ]7 [: {- @
        ' x( V! a( }- Y5 s+ Z
          【摘要】
, k: g& @+ r) T# ?' X; \      Close-arterial infusion of test substances allows one to study the responses of a selected vascular bed without inducing confounding systemic effects. Unfortunately, laminar flow patterns within the artery cause streaming of the injected factor, so that distribution within the target organ is not homogeneous. We describe a reliable method of overcoming these problems. Specifically, we attach a vibrator (i-Vibe egg) to the syringe containing the test substance. We showed that, without vibration, infusion of a solution of Evans blue (0.5% wt/vol) results in uneven distribution of the dye in the kidney. Vibration of the syringe during infusion allows for uniform coloration of the kidney surface. There is also functional improvement of drug distribution during vibration. Renal blood flow was measured during intrarenal infusion of phenylephrine (150 µl, 0.05-0.5 µg). Vibration caused a significant leftward shift in the dose-response curve, i.e., the phenylephrine-induced reduction in renal blood flow was enhanced by vibration. This cheap, simple method for ensuring adequate mixing of intra-arterially infused substances will facilitate not only the study of renal function in the rat but also infusion of test and therapeutic substances into other organs. ' l: m& b1 H  F; Q  ~4 Y, U' g
          【关键词】 renal artery laminar flow# S4 v4 c! Z1 v; c$ ?! _/ s
                  PHARMACOLOGICAL AGENTS are commonly administered during the course of investigating renal function. However, intravenous infusion may cause systemic effects that indirectly influence the kidney. To avoid this problem, the drugs are often infused directly into the renal artery. Unfortunately, laminar flow patterns within arteries cause streaming and uneven distribution of infusate within the organ, with the result that the drug may only partially, if at all, perfuse the vascular beds of interest ( 4, 18, 20 ). This can lead to variability of data and potential misinterpretation of the results. The general problem of streaming during intra-arterial infusion is also of clinical significance because therapeutic agents, particularly for chemotherapy, may be delivered in this manner to achieve high local concentrations without accompanying systemic toxicity ( 2, 6, 11 - 14 ).7 t' i  E8 L* d- l
' S0 i" Q6 x! s( B2 b) G0 K6 K7 v
Several investigators described protocols to improve mixing during intra-arterial injection of drugs. These involved introduction of balloon cannulae to cause turbulence ( 1 ), pulsed infusion ( 22 ), and extracorporeal blood circuits ( 4 ). In 1995, Parekh ( 18 ) devised a multiple catheter system with a magnetic pump that could draw back blood to premix with the drug to be infused. Although this technique does improve uniform delivery, it is expensive and requires extensive preparation. We describe a simple, inexpensive method to improve drug delivery to the kidney. We showed that this system improves spatial dye distribution, as well as the functional response to phenylephrine.
- ]3 s2 h( }' m1 p' |6 G
, [" ]% g$ V) Z5 k2 x3 O. yMATERIALS AND METHODS: e/ p8 q5 |9 Z, m, r" O

1 P/ K$ [+ }+ W$ x% X3 R% ]% i* aThe experimental procedures were approved by the local Animal Welfare Committee in accordance with the guidelines issued by the Canada Council on Animal Care. All animals were killed with an anesthetic overdose of pentobarbital sodium at the completion of the each experiment.
0 L, k0 K/ p; `; j
; _# E( l1 Y: @( NAnimals and housing. Male Long-Evans rats (350-550 g, Charles River) were housed for at least 1 wk in the University of Alberta Animal Facility. They were maintained on a 0.3% sodium diet and tap water ad libitum in a temperature- and humidity-controlled environment with a 12:12-h light-dark cycle.4 j" ?5 t8 n3 z# X  z. |- U0 Q
0 [1 z6 O2 `9 ^, J1 A% t8 ]; V
Anesthesia and surgery. The animals were injected with pentobarbital sodium (50 mg/kg body wt ip), followed by Inactin [Byck, ethyl-(1-methyl-propyl)-malonyl-thio-urea, 80 mg/kg body wt sc] 1 h later. Body temperature was maintained at 37°C (Homeothermic blanket, Harvard Apparatus).# [7 u7 \' }) e7 j5 M$ v2 S

( |5 |$ Y1 O/ W0 N, EThe left femoral vein was cannulated with Silastic tubing (0.51-mm ID, 0.94-mm OD, Dow Corning) and infused with isotonic saline (3 ml/h). The left femoral artery was cannulated with polyethylene tubing (PE-50 0.58-mm ID, 0.97-mm OD, VWR, Mississauga, Ontario), which was connected to a pressure transducer for online recording of mean arterial pressure (MAP). After a midline laparotomy, the intestines were reflected to the right side of the animal. The stomach was reflected onto the chest and held in position with hemostats. The spleen was detached from the stomach and gently retracted to the left side of the animal. All exteriorized organs were covered with moistened gauze and plastic wrap. The renal artery was carefully separated from the renal vein, ensuring the adventitia was left intact to preserve the renal nerves. A transit-time flow probe (Transonic Systems, Ithaca, NY) was placed around the renal artery distal to its origin from the descending aorta.
2 V2 y  ^2 j7 F3 t  b1 Z
, |6 w, G+ s! }# L7 |5 N" `7 pPreparation and insertion of renal arterial catheter. A 33-gauge stainless steel needle (Hamilton) was inserted into one end of a 10-cm length of Microline tubing (0.25-mm ID, 0.76-mm OD, Cole-Palmer, Ontario, Canada), which had been stretched to provide a tight seal around the needle. The other end of this tubing was attached to a syringe. With curved forceps, the renal artery wall was gently held up, while the 33-gauge needle was inserted at the junction of the renal artery and descending aorta ( Fig. 1 ). The needle was advanced 2 mm into the artery and held in place with a small drop of Vet Bond tissue adhesive (3M Animal Care Products, St. Paul, MN) at its point of entry into the vessel. An immediate flow of blood into the line on insertion indicated patency. It was not necessary at any time to interrupt blood flow to the kidney. The animal was left to stabilize for 40 min while MAP and renal blood flow were monitored.9 D2 \; x  X3 m" ]8 W
; }- y1 p! m9 Y4 |  ~
Fig. 1. Schematic representation of apparatus ( A ) and surgical preparation ( B ) for close-arterial injection into the kidney and measurement of renal blood flow.
3 P4 l( m5 ~8 z- [& O- n; D
3 D9 s$ p$ a0 `  v7 L5 mExperimental protocol. The vibrator (i-Vibe egg, Doc Johnson Enterprises) was attached, with plastic tape (3M Colourflex, Ontario, Canada), to the syringe to be used for dye infusion. Vibration was turned on at the lowest setting 30 s before the dye was injected. The dye solution (1 ml) was then slowly infused over a second period of 30 s. In the control group, the dye was infused in exactly the same manner, except that vibration was not applied to the syringe. Separate animals were used for the experiments with/without vibration.
) F4 Z% K$ G8 v$ @8 q7 ~$ Z; g/ |; g9 M& x) W9 Q. s- O
A similar procedure was followed for the injection of phenylephrine, except that MAP and renal blood flow values were recorded continuously online (DI-151RS, DATAQ Instruments, Adron, OH) using WINDAQ software for analysis (DATAQ Instruments). After stabilization (40 min), baseline measurements were made over 10 min. The phenylephrine was then infused over a period of 30 s at doses of 0, 0.05, 0.15, and 0.5 µg dissolved in 150 µl isotonic saline. There was a 10-min recovery period between each dose. Each animal was used for both with/without vibration experiments, with the order of testing being alternated between consecutive experiments.
/ J- J3 D4 j3 j/ T3 ~% h7 V- k9 R1 T" I! y% l/ C0 k
Drugs and solutions. Evans blue (Fisher Scientific, Ontario, Canada) was dissolved in isotonic saline (0.5% wt/vol). Solutions of phenylephrine (Sabex, Quebec, Canada) were made by serial dilution in heparinized isotonic saline (10,000 IU/l).3 z* u3 b* }. G& c1 b: B
) @  [: T- g& g" F3 C
Analysis of data and statistics. The maximal decrease in renal blood flow following infusion of each dose of phenylephrine was measured. Two-way repeated-measures ANOVA, followed by the Student-Newman-Keuls method for post hoc analysis, was used to determine the statistical significance of the change in renal blood flow between injection with/without vibration. Statistical significance was accepted at P 9 H" T. S' `9 R, v

3 }  L  _& k1 U' c: mRESULTS
. d7 a9 ]) g( Z9 B4 h  V5 e) w6 L# M2 P! C, Z0 W
Injection of dye directly into the renal artery, with no vibration, resulted in uneven patches of dye accumulation over the surface of the kidney ( Fig. 2 A ). With application of vibration to the syringe during injection, the kidney showed even mottled distribution of color over both dorsal and ventral surfaces ( Fig. 2 B ).( I8 i4 A3 X$ C/ K- _

# E8 N4 i( k# w7 J3 _( O- @. ]Fig. 2. Intrarenal arterial injection of Evans blue dye. One-milliliter bolus of Evans blue dye was injected with or without vibration. A : external appearance of the kidney after direct injection of dye with no vibration. B : external appearance of the kidney after injection with applied vibration. Outlines delineate regions of intense coloration ( A ) or uniform mottling ( B ).
! J! a7 X; _6 a! A: D* w, e* Z! ^1 D, ~* r$ r
There was no difference between the two groups with respect to baseline renal blood flow (with vibration: 6.3 ± 0.6 ml/min, n = 8; without vibration: 6.5 ± 0.6 ml/min, n = 8). Intra-arterial infusion of the 1 -adrenergic agonist phenylephrine induced a dose-dependent reduction in renal blood flow. Vibration caused a leftward shift of the dose-response curve relative to the response in the absence of vibration, i.e., there was a greater decrease in renal blood flow when the phenylephrine injection was accompanied by vibration ( Fig. 3 ). Repeated-measures two-way ANOVA confirmed that there was a significant effect of treatment (with vibration vs. without vibration: P & P7 T7 ?  s' T$ x
% a, ?2 L# }7 w
Fig. 3. Effect of vibration on change in renal blood flow induced by closearterial infusion of phenylephrine. : Vibration applied to syringe. : No vibration; n = 8. Vertical lines delineate SE. There was a significant effect of treatment (vibration) on renal blood flow ( P
. O( g: B7 S7 }$ s% e9 M1 z) M- r0 r# z
DISCUSSION
- R# J& y% n; B: Y$ u* O; D0 b
! k, n0 d. l. G# n/ m! J3 qDirect infusion of Evans blue into the renal artery resulted in uneven delivery of dye to the renal tissue. Application of vibration during the infusion improved dye distribution, so there was uniform coloration on both dorsal and ventral faces of the kidney. There was also functional improvement of drug distribution during vibration. The vascular response to phenylephrine, as reflected by the decrease in renal blood flow, was significantly greater when vibration was applied to the syringe during infusion. We suggest that transmission of vibration, both along the microline tubing and within the fluid column, causes turbulence and mixing as the infusate enters the blood stream. This ensures that as the blood flows through all downstream branches of the renal artery into the kidney, there is homogeneous delivery of a drug to the renal tissue. The greatest effect of vibration on renal blood flow (55% reduction vs. 25% reduction) occurred after infusion of phenylephrine at 1.5 x 10 -7 g (infused over 30 s, at a flow rate of 5 ml/min). Significantly, this is the concentration of phenylephrine (7.5 x 10 -7 M), which consistently induces vasoconstriction in the isolated, perfused kidney ( 17, 19 ).
: k( d+ ]/ p) y: X+ n
9 r2 [$ a$ E" C* J: p. x: `The issue of streaming in arterial flow has been extensively studied, at least in part, because of the clinical importance of delivering chemotherapeutic drugs to target organs where treatment may be complicated by uneven distribution and focal toxicity ( 2, 3, 5, 6, 14 ). Variable delivery of tracer due to streaming has also been demonstrated in life-sized glass models of the human hepatic artery ( 15 ), the human carotic artery ( 11 ), and the human iliofemoral/pelvic arteries ( 12 ), as well as during carotid artery infusion in rats ( 20 ). Our data were in agreement with those obtained by Parekh ( 18 ) that closearterial infusion of dye into the rat kidney normally results in extremely uneven distribution of coloration.  W. Y3 C- D& O% B2 ]; V4 v
8 T/ m- Z' X) J9 g( r
The cannulation technique and the use of the vibrator offer several advantages over previously reported methods of infusing drugs into the kidney of the rat. In contrast to most other techniques, renal blood flow does not have to be interrupted, even momentarily, during the cannulation procedure. Although Fine et al. ( 7 ) acknowledge that blood flow should not be stopped for more than 10 to 20 s, it is our experience that ligating the aorta or renal artery results in almost immediate blanching of the kidney. This will undoubtedly induce both direct (renin release) and indirect (renal afferent nerve activity) responses to alter both renal function and systemic hemodynamics ( 9, 16 ).
8 \" v+ G) X2 P- ^' b) ^
. I. Z8 p- Q- IAnother approach has been to cannulate the suprarenal artery ( 10, 21 ). Not only does this fail to address the problem of streaming and uneven distribution of infusate, but we found that ligation of the suprarenal artery induced lability of the MAP, which directly affected renal blood flow (Hamza and Kaufman, unpublished observations).9 V1 j* u; r! x! k5 m6 [2 o
  a+ C2 {4 c4 m
Cupples and Sonnenberg ( 4 ) recognized the need to ensure adequate distribution of an infused drug with blood before entering the kidney. To this end, they used an extracorporeal circuit as devised by Fink and Brody ( 8 ). This circuit involved shunting blood from the carotid artery to an aortic pouch leading to the left renal artery. This enabled the test substances to be infused some distance upstream from the kidney, which ensured adequate mixing. The disadvantage of this method lies in the fact that, as admitted by the authors themselves, it is highly invasive.
0 s# a6 i8 v& u. T. H+ j$ N: F& m3 K/ @
It was in light of these previous attempts to address the problem of streaming that Parekh ( 18 ), in 1995, developed a multiple catheter system with a magnetic pump whereby blood could be drawn back and mixed with the test substance before being reinfused into the animal. Parekh showed convincingly that with this system, not only was injected dye evenly distributed in the kidney, but the renal responses to vasoactive drugs were augmented and the systemic responses were reduced. The disadvantage of this system is that it is complicated to set up, involving as it does fused multiple cannulae and a magnetic membrane pump. By contrast, our method of simply applying steady vibration to the syringe with a commercial vibrator is economical, efficient, and significantly improves drug distribution in the kidney.3 G3 m; j. }3 i* G! q

/ _4 D1 r8 i1 r) f/ oWe describe applying vibration directly to the infusion syringe. However, the system worked equally well when the vibrator was taped to the hard plastic male adapter on an intravenous infusion set (Abbott Laboratories); this would allow one to use a syringe pump or a peristaltic pump placed upstream of the vibrator to administer the solution. Moreover, one may use either a flank or a midline approach to the kidney, because the vibrator is applied several centimeters distal to the tip of the cannula ( Fig. 1 ). The ability to ensure homogeneous drug distribution during close-arterial infusion is critical to ensuring meaningful, reproducible experimental data, not only in the kidney, but also in other target organs such as the brain and liver.
9 a7 k  G0 b* t/ L: v+ t) ?4 |& j6 @4 B4 P9 j; Y: y* Q: A
ACKNOWLEDGMENTS
1 z7 e& J* O/ E' k" C6 u$ T8 P/ }( k, G8 Q
We acknowledge the technical assistance of J. Levasseur.& z5 b4 W# v9 h5 B# E- z1 y7 a$ s

/ D  _8 C8 l9 CGRANTS. o& `! d# d" `* a* s* A- k) V
0 A9 a. `# i) |& r4 d' y* @0 \
This research was supported by research grants from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Alberta, the Northwest Territories, and Nunavut.; _4 {4 ?, R$ h' Q! I) \
          【参考文献】( e! |  ~$ M* w
Barth KH, Lutz RJ, Kremers PW, and Miller DL. Mixing problems of low flow hepatic artery infusion. Improvement with small caliber double lumen balloon catheters. Invest Radiol 23: 519-523, 1988.  K- g9 H# \7 C% M/ P" k/ V+ h

( D" E8 T+ i" r/ a9 Q3 J. S' T& g' O% z4 ]( n. B* p8 j
6 h0 X5 \( z- X( H2 j$ ]
Bayar S, Unal E, Tez M, Kocaoglu H, Demirci S, and Akgul H. Regional chemotherapy for advanced pancreatic carcinoma. Hepatogastroenterology 50: 550-552, 2003.( e4 n/ w, ~  F# i
5 @0 h6 Y& R" u1 ?- O4 f9 o6 @

) ]5 d$ ~. t' Q! a7 o. v5 f# d; n( d4 O& W4 {* O
Blacklock JB, Wright DC, Dedrick RL, Blasberg RG, Lutz RJ, Doppman JL, and Oldfield EH. Drug streaming during intra-arterial chemotherapy. J Neurosurg 64: 284-291, 1986.; `- ^1 x8 S! x% U' W( j9 E
! N+ L+ O( t; d" d; \" S
! q3 l/ I5 R. A; L4 e- R
6 A: w+ X! V; N- d. p- i, s
Cupples WA and Sonnenberg H. Renal medullary plasma flow rate and reabsorption of salt and water from inner medullary collecting duct. Can J Physiol Pharmacol 65: 2415-2421, 1987.
) g) r2 u0 r4 o
8 g2 F- S- t( f" O5 R# {  t
& B, O' Y7 q/ G; Z6 C7 i) ]& f2 V7 ~( R8 q
Dedrick RL. Arterial drug infusion: pharmacokinetic problems and pitfalls. J Natl Cancer Inst 80: 84-89, 1988.
' e8 h+ f7 d5 K  c7 N  b8 s" }/ I' P" m* T
5 c  r& z3 f- r
+ z5 E* L3 d8 K; [, i7 `8 ?6 q
Doolittle ND, Miner ME, Hall WA, Siegal T, Jerome E, Osztie E, McAllister LD, Bubalo JS, Kraemer DF, Fortin D, Nixon R, Muldoon LL, and Neuwelt EA. Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors. Cancer 88: 637-647, 2000. <a href="/cgi/external_ref?access_num=10.1002/(SICI)1097-0142(20000201)88:3
4 p6 F" S. z6 d9 Z: A2 S: @
9 _& V' Z2 S6 g; Z- G, N% e" m) ]( j; n/ Y

- G. s0 Z. d6 x, \) G" E1 y. gFine LG, Lee H, Goldsmith D, Weber H, and Blaufox MD. Effects of catheterization of renal artery on renal function in the rat. J Appl Physiol 37: 930-933, 1974.
5 G9 C; a5 x; x8 M) o- H% Y$ ?( T/ p# ]2 ]0 h

. c+ I' N0 ~; z% k" U% q
. i$ m- {9 R7 @& `7 n1 @  T+ BFink GD and Brody MJ. Continuous measurement of renal blood flow changes to renal nerve stimulation and intra-arterial drug administration in the rat. Am J Physiol Heart Circ Physiol 234: H219-H222, 1978.7 T8 L5 `# K4 n  l0 j
/ M. n7 ?5 l! |6 N0 o( t6 Z

) a& N) n4 _( L! {2 K
' }. |7 w0 Q( T0 FKaufman JS, Hamburger RJ, and Flamenbaum W. Renal renin responses to changes in volume status and perfusion pressure. Am J Physiol Renal Fluid Electrolyte Physiol 238: F488-F490, 1980.; Q  j) J" R* T  o# _3 f% ?

5 O8 D) M4 \2 U" w1 O# H, f% ~5 w, t4 _; W% B
8 `6 {3 F$ B* a1 ~1 \6 U) V
Kleinjans JC, Smits JF, van Essen H, and Struyker-Boudier HA. Hemodynamic effects of intrarenal noradrenaline infusion in conscious rats. Fed Proc 41: 1660, 1982.
# t$ r7 v, x. {/ a% n* }8 l1 F: R' g4 D, g. e

. j2 B5 p9 N( F) j/ w" o. O" E
- g/ I, q8 E& G) |9 LLutz RJ, Dedrick RL, Boretos JW, Oldfield EH, Blacklock JB, and Doppman JL. Mixing studies during intracarotid artery infusions in an in vitro model. J Neurosurg 64: 277-283, 1986.
# E2 I6 ?! ^4 A# I) b
  c  G' Z! q9 q5 ^% S9 E( C2 K, e: n' R, }  H

" L! ]6 g: s' ^Lutz RJ, Epstein AH, Cook JA, and Dedrick RL. An in vitro flow model to study streaming during pelvic intra-arterial drug infusions. Gynecol Oncol 59: 288-296, 1995.+ ]  U! Y1 y) b2 q& l, B" j1 s
. J0 h4 Y( _6 Y4 u: C7 M. m

1 |% {2 r; M7 Z3 q
& d3 g$ Y. O% U* y3 c# d( g$ ULutz RJ, Warren K, Balis F, Patronas N, and Dedrick RL. Mixing during intravertebral arterial infusions in an in vitro model. J Neurooncol 58: 95-106, 2002.9 K' j6 J1 t$ Y* r& Q

/ y' J7 l" d$ b, c3 }6 P7 v3 l( S* c' i% |4 X7 o
" O/ X3 A* f/ ^
Mancini R, Tedesco M, Garufi C, Filippini A, Arcieri S, Caterino M, Pizzi G, Cortesi E, Spila A, Sperduti I, and Cosimelli M. Hepatic arterial infusion (HAI) of cisplatin and systemic fluorouracil in the treatment of unresectable colorectal liver metastases. Anticancer Res 23: 1837-1841, 2003.
$ M' m7 S+ L) V" ?1 [
/ l9 a- }( x- O; n
3 x2 H9 D# `4 ~4 l( o
* q/ S7 R% J; Z+ sMatsumoto AH, Barth KH, Lutz RJ, and Miller DL. Hepatic artery model for evaluating the distribution of intraarterial chemotherapy infusion: nonpulsed vs. pulsed infusions. Radiology 170: 1077-1080, 1989.* D6 e2 A$ n) e# T( ~( @. Y

0 R& s; x0 x" S% z/ f
  m  o3 G5 z$ L$ J- ?" L6 ~
" G6 r) R7 @9 q& E/ v! FMoss NG. Electrophysiological characteristics of renal sensory receptors and afferent renal nerves. Miner Electrolyte Metab 15: 59-65, 1989.! ], T7 i% ^7 b: h7 [

! i  h2 N# O3 u' m( l" [' k/ ]" ^2 B% ?6 u
! x3 K- I" K* v7 f4 g
Oyekan A. Nitric oxide inhibits renal cytochrome P450-dependent epoxygenases in the rat. Clin Exp Pharmacol Physiol 29: 990-995, 2002.
' A: C0 b% D4 n& M+ H" R2 E7 z; W! `2 f* j- c5 B7 r# X+ G/ a8 R
3 b2 A7 U/ t7 n" K3 E0 X' N9 _

5 M. Q2 I+ I1 X, c: M, j, LParekh N. A novel method for infusing drugs continuously into the renal artery of rats. Am J Physiol Renal Fluid Electrolyte Physiol 268: F967-F971, 1995.. S0 A! g, J6 g$ o1 `
% g1 S5 k. w0 E: Y8 ~4 N
, G' y+ H- i% q" ^
1 C1 b& A% _) V4 X3 \" M
Quilley J, Qiu Y, and Hirt J. Inhibitors of 20-hydroxyeicosatetraenoic acid reduce renal vasoconstrictor responsiveness. J Pharmacol Exp Ther 307: 223-229, 2003.
" H1 D$ n/ U9 c1 M8 {3 G* Y8 s
4 g: q  Z* i! ~
0 c# U8 N+ ]* B; u  a* V9 S" a
: q9 S/ L+ ~1 i& Z0 aSaris SC, Wright DC, Oldfield EH, and Blasberg RG. Intravascular streaming and variable delivery to brain following carotid artery infusions in the Sprague-Dawley rat. J Cereb Blood Flow Metab 8: 116-120, 1988.
! p2 O/ H  [9 a7 C2 ~/ l6 V' \: h" \) R' {0 z! \

5 {: ^$ `7 e) L6 O# E% U
' q3 v( L# x3 n' o# l( cSmits JF, Kasbergen CM, van Essen H, Kleinjans JC, and Struyker-Boudier HA. Chronic local infusion into the renal artery of unrestrained rats. Am J Physiol Heart Circ Physiol 244: H304-H307, 1983.- \0 \+ p1 T5 O

1 }6 K6 l- B% s1 V" k  q
* a8 b8 ?4 v; h; Y- z$ }
! c; `2 }# Z  QWright KC, Wallace S, Kim EE, Haynie T, Charnsangavej C, Carrasco CH, Chuang VP, and Gianturco C. Pulsed arterial infusions. Chemotherapeutic implications. Cancer 57: 1952-1956, 1986. <a href="/cgi/external_ref?access_num=10.1002/1097-0142(19860515)57:10
作者: 剑啸寒    时间: 2015-5-31 18:09

不早了 各位晚安~~~~  
作者: foxok    时间: 2015-6-2 22:05

回复一下  
作者: txxxtyq    时间: 2015-7-21 23:01

想都不想,就支持一下  
作者: 泡泡鱼    时间: 2015-7-25 03:45

真的有么  
作者: biobio    时间: 2015-8-5 11:25

这样的贴子,不顶说不过去啊  
作者: 罗马星空    时间: 2015-8-19 17:43

小心大家盯上你哦  
作者: 石头111    时间: 2015-8-30 19:01

干细胞行业门户 干细胞之家
作者: 石头111    时间: 2015-9-10 15:10

支持你一下下。。  
作者: tuanzi    时间: 2015-9-16 15:43

谢谢楼主啊!
作者: bluesuns    时间: 2015-10-12 11:43

挺好啊  
作者: yukun    时间: 2015-10-15 14:17

原来这样也可以  
作者: 科研人    时间: 2015-11-1 17:34

应该加分  
作者: dypnr    时间: 2015-11-28 11:27

一个人最大的破产是绝望,最大的资产是希望。  
作者: laoli1999    时间: 2015-12-9 23:25

不要等到人人都说你丑时才发现自己真的丑。  
作者: tuanzi    时间: 2016-1-5 19:01

今天无聊来逛逛  
作者: 榴榴莲    时间: 2016-1-25 09:01

我在顶贴~!~  
作者: 风云动    时间: 2016-2-17 18:18

神经干细胞
作者: aliyun    时间: 2016-4-10 17:53

皮肤干细胞
作者: 咖啡功夫猫    时间: 2016-4-14 11:18

发贴看看自己积分  
作者: 狂奔的蜗牛    时间: 2016-4-27 15:01

真是汗啊  我的家财好少啊  加油  
作者: biodj    时间: 2016-7-5 19:01

越办越好~~~~~~~~~`  
作者: netlover    时间: 2016-7-7 17:27

好贴子好多啊  
作者: leeking    时间: 2016-7-10 18:26

先看看怎么样!  
作者: Greatjob    时间: 2016-8-1 09:01

彪悍的人生不需要解释。  
作者: tuting    时间: 2016-9-3 23:10

干细胞研究还要面向临床
作者: 海小鱼    时间: 2016-9-14 21:42

干细胞存储  
作者: 快乐小郎    时间: 2016-11-12 19:02

楼主good  
作者: xiao2014    时间: 2017-1-13 20:16

顶的就是你  
作者: 8666sea    时间: 2017-1-17 17:27

厉害!强~~~~没的说了!  
作者: 未必温暖    时间: 2017-2-20 18:14

谁能送我几分啊  
作者: Whole    时间: 2017-3-3 01:02

顶顶更健康,越顶吃的越香。  
作者: 狂奔的蜗牛    时间: 2017-3-4 12:40

顶下再看  
作者: feixue66    时间: 2017-3-12 13:09

真是佩服得六体投地啊  
作者: 三星    时间: 2017-3-15 01:16

世界上那些最容易的事情中,拖延时间最不费力。  
作者: 桦子    时间: 2017-3-17 12:35

佩服佩服啊.  
作者: 20130827    时间: 2017-3-29 04:01

感谢党和人民的关爱~~~  
作者: dr_ji    时间: 2017-4-4 12:40

帮顶  
作者: 蚂蚁    时间: 2017-4-12 11:52

很有吸引力  
作者: 昕昕    时间: 2017-4-15 17:16

谢谢分享了!   
作者: 刘先生    时间: 2017-5-1 01:00

加油啊!偶一定会追随你左右,偶坚定此贴必然会起到抛砖引玉的作用~  
作者: ikiss    时间: 2017-5-26 02:17

谁都不容易啊 ~~  
作者: lab2010    时间: 2017-5-29 09:27

干细胞我这辈子就是看好你
作者: Kuo    时间: 2017-6-24 15:35

哈哈,看的人少,回一下  
作者: 咖啡功夫猫    时间: 2017-7-2 19:27

强人,佩服死了。呵呵,不错啊  
作者: immail    时间: 2017-7-9 16:53

干细胞与基因技术
作者: xuguofeng    时间: 2017-7-10 11:27

谢谢楼主啊!
作者: aliyun    时间: 2017-7-13 20:09

帮你项项吧  
作者: 天蓝色    时间: 2017-7-31 02:42

我等你哟!  
作者: 3344555    时间: 2017-8-1 17:12

似曾相识的感觉  
作者: pengzy    时间: 2017-8-3 06:35

干细胞产业是朝阳产业
作者: 石头111    时间: 2017-8-7 21:27

回贴赚学识,不错了  
作者: 糊涂小蜗牛    时间: 2017-8-17 20:29

(*^__^*) 嘻嘻……  
作者: 舒思    时间: 2017-8-18 11:34

老大,我好崇拜你哟  
作者: Whole    时间: 2017-8-24 15:54

不错,看看。  
作者: laoli1999    时间: 2017-9-1 07:44

孜孜不倦, 吾等楷模 …………  
作者: 丸子    时间: 2017-9-1 10:35

我在顶贴~!~  
作者: tian2006    时间: 2017-9-11 12:10

想都不想,就支持一下  
作者: xiao2014    时间: 2017-9-19 04:39

支持一下  
作者: Diary    时间: 2017-9-25 06:16

哈哈 我支持你
作者: 杏花    时间: 2017-10-14 23:01

抢座位来了  
作者: 修复者    时间: 2017-10-24 14:13

快毕业了 希望有个好工作 干细胞还是不错的方向
作者: 3344555    时间: 2017-11-27 23:54

真是汗啊  我的家财好少啊  加油  
作者: 未必温暖    时间: 2017-12-26 15:18

慢慢来,呵呵  
作者: Whole    时间: 2018-1-13 09:01

不是吧  
作者: immail    时间: 2018-1-28 21:12

不错的东西  持续关注  
作者: 追风    时间: 2018-2-24 00:47

抢座位来了  
作者: yunshu    时间: 2018-4-13 10:10

留个脚印```````  
作者: bluesuns    时间: 2018-4-13 19:23

肌源性干细胞
作者: cjms    时间: 2018-4-26 01:07

继续查找干细胞研究资料
作者: chongchong    时间: 2018-5-1 09:27

正好你开咯这样的帖  
作者: 生物小菜鸟    时间: 2018-5-15 20:08

免疫细胞疗法治疗肿瘤有效  
作者: 初夏洒脱    时间: 2018-6-2 13:54

不知道说些什么  
作者: Kuo    时间: 2018-6-4 01:59

谢谢分享  
作者: chongchong    时间: 2018-6-4 08:01

干细胞研究重在基础
作者: dogcat    时间: 2018-6-14 23:36

支持一下吧  
作者: 多来咪    时间: 2018-6-15 05:43

加油啊!偶一定会追随你左右,偶坚定此贴必然会起到抛砖引玉的作用~  
作者: laoli1999    时间: 2018-6-17 05:39

貌似我真的很笨????哎  
作者: dada    时间: 2018-6-28 15:43

干细胞与动物克隆
作者: yukun    时间: 2018-7-2 16:01

好 好帖 很好帖 确实好帖 少见的好帖  
作者: sky蓝    时间: 2018-9-18 17:58

帮你顶,人还是厚道点好  
作者: 海小鱼    时间: 2018-9-24 05:18

似曾相识的感觉  
作者: awen    时间: 2018-10-1 00:47

呵呵,明白了  
作者: yukun    时间: 2018-10-5 06:10

照你这么说真的有道理哦 呵呵 不进沙子馁~~~  
作者: tuting    时间: 2018-10-24 07:29

脂肪干细胞
作者: 咖啡功夫猫    时间: 2018-12-2 01:34

间充质干细胞
作者: yukun    时间: 2018-12-3 15:08

我的妈呀,爱死你了  
作者: 旅美学者    时间: 2018-12-13 09:43

不错啊! 一个字牛啊!  
作者: ringsing    时间: 2018-12-17 17:20

祝干细胞之家 越办越好~~~~~~~~~`  
作者: s06806    时间: 2019-1-12 21:10

谢谢干细胞之家提供资料
作者: 剑啸寒    时间: 2019-2-19 11:10

好啊,,不错、、、、  
作者: biodj    时间: 2019-2-23 22:29

我好想升级  
作者: 张佳    时间: 2019-2-25 23:43

我该不会是最后一个顶的吧  
作者: 再来一天    时间: 2019-3-5 08:35

干细胞疾病模型
作者: tuting    时间: 2019-3-12 14:01

干细胞与基因技术
作者: Whole    时间: 2019-4-23 00:47

我回不回呢 考虑再三 还是不回了吧 ^_^  
作者: 温暖暖    时间: 2019-6-6 02:46

都是那么过来的  
作者: popobird    时间: 2019-6-21 06:39

围观来了哦  
作者: 锦锦乐道    时间: 2019-6-28 04:57

我顶啊。接着顶  
作者: 泡泡鱼    时间: 2019-7-4 22:05

呵呵 高高实在是高~~~~~  




欢迎光临 干细胞之家 - 中国干细胞行业门户第一站 (http://www.stemcell8.cn/) Powered by Discuz! X1.5